Aerska raises $39M to help RNA medicines reach the brain

Aerska raises $39M to help RNA medicines reach the brain


For families living with neurodegenerative disease, the hardest part is not always the diagnosis. It is the slow erosion that follows: memory fading, personality shifting, independence shrinking. It unfolds quietly. First, forgotten appointments. Then repeated questions. Then moments when a familiar face no longer feels familiar. The illness does not isolate itself to one body. It rearranges the lives around it. Partners become caregivers. Children become decision-makers. Conversations grow shorter. Patience grows thinner. Guilt creeps in, for being tired, for wishing things were easier, for missing the person who is still physically there. Neurodegeneration is rarely a single patient story.…

This story continues at The Next Web
  1. No comment added yet!
  2. Leave Your Comment

    Your email address will not be published. Required fields are marked *

AtSign Innovations